Atea Pharmaceuticals, Inc. (AVIR) Net margin 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) net profit margin by fiscal year — reported net income divided by reported revenue.
-33.0%FY2022 · since FY2021: 248.8% → -33.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -33.0% | -281.8 pp |
| FY2021 | 248.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice